Report

src

Global Stents Market Size, Share & COVID-19 Impact Analysis, By Product (Coronary Stents, Drug-Eluting Stents (DES), Bare-Metal Coronary Stents, Bioabsorbable Stents, Peripheral Stents, Iliac Stent, Femoral-Popliteal Stents, Renal & Related Stents, Carotid Stents, Stent Related Implant, Synthetic Grafts and Vena Cava Filters), By Material (Metallic Biomaterial, Polymer Biomaterial and Natural Biomaterial), By End User (Hospital, Ambulatory Surgical Centers and Others) and Regional Forecasts, 2022-2028

The global stents market size was valued at USD 8.3 billion in 2021. The market is projected to grow from USD 8.3 billion in 2021 to USD 10.4 billion by 2028, exhibiting a CAGR of 3.80% during the forecast period.
 
A medical device called a stent is inserted into a blocked passageway to keep it open. This medical device is shaped like a tiny tube and is either made of plastic or metal. It helps restore blood flow and other bodily fluids to various organs. Another key factor boosting the stents market is the prevalence of coronary artery disease. The market is growing due to increased demand for minimally invasive surgery due to benefits like quick recovery and reduced pain. Additionally, the market is further influenced by the increase in funding from both public and private organizations for the growth of the healthcare industry. Furthermore, during the projection period, medical device advances open up lucrative potential for market participants. Moreover, bioresorbable vascular scaffolds will boost the market growth.
 
COVID-19 IMPACT

The COVID-19 pandemic's emergence has affected the global market share for stents and disrupted the healthcare industry. The healthcare system was severely disrupted by the rising number of COVID-19 cases worldwide, which led to significant backlogs in non-essential surgeries, suspension of those procedures, and delays in diagnosing non-emergency disease conditions. Because of the strictly enforced lockdown, the supply and manufacturing chains were disrupted, which resulted in a constrained supply of stents for end users. Several regulatory bodies placed restrictions on the movement of people and goods while stopping non-urgent surgical procedures like angioplasty and bypass surgeries. Thus, the elements above negatively impacted the expansion of the global stents market.
 
DRIVING FACTORS

Cardiovascular Problems are on the Rise, which will Boost Sales

The expansion of the stents market in the coming years is predicted to be positively impacted by the rising prevalence of cardiovascular illnesses worldwide. Demand for peripheral vascular and percutaneous coronary interventions is anticipated to rise as the number of patients with chronic conditions rises. For instance, the World Health Organization (WHO) estimates that 17.9 million deaths yearly are attributed to cardiovascular diseases (CVDs), or almost 32% of all fatalities. The demand for peripheral vascular and percutaneous coronary interventions will rise as the number of people with cardiovascular diseases rises steadily, ultimately fueling the demand for stents.
 
RESTRAINING FACTORS

Stringent Regulations Could Prevent the Market from Growing

Strict regulatory approvals may be a barrier to stents' market growth. Numerous authorities and government organizations have established rules and guidelines for stents' efficient and secure use. For instance, the U.S. FDA reviews the literature and animal pre-clinical trials before approving stents. The U.S. FDA classifies coronary stents as a category III device, so approving a medical device is also thought to be resource-intensive (in terms of both time and money). Due to the complications associated with using stents, strict regulations have been implemented. The U.S. FDA carefully monitors the use of stents due to potentially fatal outcomes.
 
SEGMENTATION

By Product


Based on product, the stents market is segmented into coronary stents, drug-eluting stents (DES), bare-metal coronary stents, bioabsorbable stents, peripheral stents, iliac stents, femoral-popliteal stents, renal & related stents, carotid stents, stent-related implant, synthetic grafts, and vena cava filters. The coronary stents category dominated the market in 2021 due to rising rates of coronary artery disease, technological developments in the pharmaceutical and biotechnology sectors, and a boom in drug-eluting stents. However, the peripheral stents market is anticipated to expand significantly over the forecast year due to rising peripheral artery disease prevalence and an increase in the number of major stent manufacturers.
 
By Material

By material, the market is segmented into metallic biomaterial, polymer biomaterial and natural biomaterial. The metallic biomaterial category dominated the market in 2021. The demand for metallic biomaterial stents rises due to their benefits, including lower rates of stent fracture, biocompatibility, and flexibility, which support market growth. Another element driving the segment's growth and bolstering market predictions is the incorporation of metallic biomaterial with biodegradable polymer to overcome the limits of conventional goods.
 
By End User

By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospital category dominated the market in 2021. Hospitals are known to have developed infrastructure with the modern medical equipment necessary for successful stent procedures. Stents used frequently in minimally invasive surgical procedures are regarded as crucial pieces of medical gear. Hospitals provide better care because they have access to qualified medical and nursing staff who can provide efficient post-operative care.
 
REGIONAL INSIGHTS

 
North America is projected to hold the largest share of the stents market over the forecast period due to an increase in the number of older individuals and the frequency of cardiovascular disease. For instance, 54.1 million Americans aged 65 and over were living in the United States as of 2019, according to the Administration of Community Living. The risk of CVD and many other related health conditions, including coronary heart disease and angioplasty, rises with age. Therefore, it is anticipated that using stents for these illnesses will accelerate market expansion. Furthermore, throughout the forecast period, the regional stents industry landscape is anticipated to benefit from the presence of significant market players in the area.
 
On the other hand, the Asia Pacific stents market is anticipated to grow significantly over the forecast period due to rising in the prevalence of coronary artery disease, an increase in the population of seniors, an increase in health care spending, and a rise in the adoption of unhealthy lifestyles. In addition, developments in stent technology over the past three decades, including biodegradable materials and bifurcated stents, have contributed to the market's expansion.
 
LIST OF KEY COMPANIES PROFILED:
  • BIOTRONIK
  • Medtronic, BD
  • Boston Scientific Corporation
  • Abbott.
  • Cardinal Health
  • Elixir Medical Corporation
  • Terumo Corporation
  • Biosensors International Group, Ltd
  • Meril Life Sciences Pvt. Ltd.
  • Others
 
KEY INDUSTRY DEVELOPMENTS:
  • May 2021: iVascular's Balloon-expanding (BX) covered stent, iCover, was given CE mark clearance. It is used to treat ruptures, aneurysms, and arteriosclerotic lesions in the iliac and renal arteries. The company was able to grow because of this tactic.
  • December 2020: The National Medical Products Administration (NMPA) of China has granted MicroPort Scientific a registration certificate for their Bridge vertebral drug-eluting stent, the company reported. The device has a novel drug delivery system that enables quicker endothelialization and lower thromboembolic and restenosis events. The approval strengthens the company's market presence.
REPORT SCOPE AND SEGMENTATION
 
Attributes Details
Study Period 2016-2028
Base Year 2021
Estimated Year 2022
Forecast Period 2022-2028
Historical Period 2016-2020
Unit Revenue (USD Million) and Volume (Kilo Tons)
Segmentation By Product, By Material, By End User and By Geography
By Product
  • Coronary Stents
  • Drug-Eluting Stents (DES)
  • Bare-Metal Coronary Stents
  • Bioabsorbable Stents
  • Peripheral Stents
  • Iliac Stent
  • Femoral-Popliteal Stents
  • Renal & Related Stents
  • Carotid Stents
  • Stent Related Implants
  • Synthetic Grafts
  • Vena Cava Filters
By Material
  • Metallic Biomaterial 
  • Polymer Biomaterial 
  • Natural Biomaterial
By End User
  • Hospital 
  • Ambulatory Surgical Centers 
  • Others
By Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa
Chapter No. 1 :    Preface

    1.1.    Report Scope and Description
        1.1.1.    Study Purpose
        1.1.2.    Target Audience
        1.1.3.    USP and Key Products
    1.2.    Key Benefits for Stakeholders
    1.3.    Report Scope

Chapter No. 2 :    Report Summary

    2.1.    Key Findings
        2.1.1.    Top Investment Pockets
        2.1.1.1.    Stents Market Attractiveness Analysis, By Product
        2.1.1.2.    Stents Market Attractiveness Analysis, By Material
        2.1.1.3.    Stents Market Attractiveness Analysis, By End User
        2.1.1.4.    Stents Market Attractiveness Analysis, By Region
    2.2.    Market Snapshot: Global Stents Market
    2.3.    Global Stents Market, 2022 – 2028 (US$ Mn)

Chapter No. 3 :    Covid 19 Impact Analysis

    3.1.    Impact Assessment of COVID-19 Pandemic, By Region
        3.1.1.    North America: Impact of COVID-19 Pandemic
        3.1.2.    Europe: Impact of COVID-19 Pandemic
        3.1.3.    Asia Pacific: Impact of COVID-19 Pandemic
        3.1.4.    Latin America: Impact of COVID-19 Pandemic
        3.1.5.    The Middle-East and Africa: Impact of COVID-19 Pandemic
    3.2     Key Strategies Undertaken by Companies to Tackle COVID-19
    3.3.    Quarterly Market Revenue by Region 2021 & 2022
    3.4.    Pre COVID-19 Market Revenue, By Region, 2016-2019 (US$ Mn)
    3.5.    Post COVID-19 Market Revenue, By Region, 2020-2028 (US$ Mn)
    3.6.    Short Term Dynamics
    3.7.    Long Term Dynamics

Chapter No. 4 :    Stents Market – By Product Segment Analysis

    4.1.    Stents Market Overview, By Product Segment
        4.1.1.    Stents Market Revenue Share, By Product, 2021 & 2028
    4.2.    Dental Systems & Equipment
    4.3.    Dental Implants
    4.4.    Dental Implants
    4.5.    Dental Bridges
    4.6.    Dental Veneers
    4.7.    Dental Crowns
    4.8.    Orthodontic Braces
    4.9.    Inalys & Onlays

Chapter No. 5 :    Stents Market – By Material Segment Analysis

    5.1.    Stents Market Overview, By Material Segment
        5.1.1.    Stents Market Revenue Share, By Material, 2021 & 2028
    5.2.    Dental Hospitals and Clincs
    5.3.    Dental Laboratories
    5.4.    Others

Chapter No. 6 :    Stents Market – By End User Segment Analysis

    6.1.    Stents Market Overview, By End User Segment
        6.1.1.    Stents Market Revenue Share, By End User, 2021 & 2028
    6.2.    Children
    6.3.    Adults

Chapter No. 7 :    Stents Market – Regional Analysis

    7.1.    Stents Market Overview, by Region Segment
        7.1.1.    Global Stents Market Revenue Share, By Region, 2021 & 2028
        7.1.2.    Global Stents Market Revenue, By Region, 2017 – 2028 (US$ Mn)
        7.1.3.    Global Stents Market Revenue, By Product, 2017 – 2028 (US$ Mn)
        7.1.4.    Global Stents Market Revenue, By Material, 2017 – 2028 (US$ Mn)
        7.1.5.    Global Stents Market Revenue, By End User, 2017 – 2028 (US$ Mn)
    7.2.    North America
        7.2.1.    North America Stents Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        7.2.2.    North America Stents Market Revenue, By Product, 2018 – 2028
        7.2.3.    North America Stents Market Revenue, By Material, 2018 – 2028
        7.2.4.    North America Stents Market Revenue, By End User, 2018 – 2028
        7.2.5.    U.S. Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.2.6.    Canada Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.2.7.    Mexico Stents Market Revenue, 2016 - 2028 (US$ Mn)
    7.3.    Europe
        7.3.1.    Europe Stents Market Revenue, By Country, 2022 – 2028 (US$ Mn)
        7.3.2.    Europe Stents Market Revenue, By Product, 2022 – 2028
        7.3.3.    Europe Stents Market Revenue, By Material, 2022 – 2028
        7.3.4.    Europe Stents Market Revenue, By End User, 2022 – 2028
        7.3.5.    Germany Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.3.6.    France Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.3.7.    U.K. Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.3.8.    Italy Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.3.9.    Spain Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.3.10.    Rest of Europe Stents Market Revenue, 2016 - 2028 (US$ Mn)
    7.4.    Asia Pacific
        7.4.1.    Asia Pacific Stents Market Revenue, By Country, 2022 – 2028 (US$ Mn)
        7.4.2.    Asia Pacific Stents Market Revenue, By Product, 2022 – 2028
        7.4.3.    Asia Pacific Stents Market Revenue, By Material, 2022 – 2028
        7.4.4.    Asia Pacific Stents Market Revenue, By End User, 2022 – 2028
        7.4.5.    China Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.4.6.    Japan Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.4.7.    India Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.4.8.    South Korea Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.4.9.    South-East Asia Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.4.10.    Rest of Asia Pacific Stents Market Revenue, 2016 - 2028 (US$ Mn)
    7.5.    Latin America
        7.5.1.    Latin America Stents Market Revenue, By Country, 2022 – 2028 (US$ Mn)
        7.5.2.    Latin America Stents Market Revenue, By Product, 2022 – 2028
        7.5.3.    Latin America Stents Market Revenue, By Material, 2022 – 2028
        7.5.4.    Latin America Stents Market Revenue, By End User, 2022 – 2028
        7.5.5.    Brazil Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.5.6.    Argentina Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.5.7.    Rest of Latin America Stents Market Revenue, 2016 - 2028 (US$ Mn)
    7.6.    The Middle-East and Africa
        7.6.1.    The Middle-East and Africa Stents Market Revenue, By Country, 2022 – 2028 (US$ Mn)
        7.6.2.    The Middle-East and Africa Stents Revenue, By Product, 2022 – 2028
        7.6.3.    The Middle-East and Africa Stents Market Revenue, By Material, 2022 – 2028
        7.6.4.    The Middle-East and Africa Stents Market Revenue, By End User, 2022 – 2028
        7.6.5.    GCC Countries Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.6.6.    South Africa Stents Market Revenue, 2016 - 2028 (US$ Mn)
        7.6.7.    Rest of Middle-East Africa Stents Market Revenue, 2016 - 2028 (US$ Mn)

Chapter No. 8 :    Stents Market – Industry Analysis

    8.1.    Introduction
    8.2.    Market Drivers
        8.2.1.    Driving Factor 1 Analysis
        8.2.2.    Driving Factor 2 Analysis
    8.3.    Market Restraints
        8.3.1.    Restraining Factor Analysis
    8.4.    Market Opportunities
        8.4.1.    Market Opportunity Analysis
    8.5.    Porter’s Five Forces Analysis
    8.6.    PEST Analysis
    8.7.    Regulatory Landscape
    8.8.    Technology Landscape
    8.9.    Value Chain Analysis

Chapter No. 9 :    Competitive Landscape

    9.1.    Company Market Share Analysis – 2021
        9.1.1.    Global Stents Market: Company Market Share, 2022
        9.1.2    Global Stents Market: Company Market Share, 2022
    9.2.    Strategic Developments
        9.2.1.    Acquisitions & Mergers
        9.2.2.    New Product Launch
        9.2.3.    Regional Expansion
    9.3.    Company Strategic Developments – Heat Map Analysis

Chapter No. 10 : Company Profiles

    10.1.    BIOTRONIK
        10.1.1.    Company Overview
        10.1.2.    Key Executives
        10.1.3.    Product Portfolio
        10.1.4.    Financial Overview
        10.1.5.    Operating Business Segments
        10.1.6.    Business Segment Performance
        10.1.7.    Recent Developments
    10.2.    Medtronic, BD
    10.3.    Boston Scientific Corporation
    10.4.    Abbott.
    10.5.    Cardinal Health
    10.6.    Elixir Medical Corporation
    10.7.    Terumo Corporation
    10.8.    Biosensors International Group, Ltd
    10.9.    Meril Life Sciences Pvt. Ltd.
    10.10.    Others

Chapter No. 11 :    Research Methodology

    11.1.    Research Methodology
    11.2.    Phase I - Secondary Research
    11.3.    Phase II - Data Modeling
        11.3.1.    Company Share Analysis Model
        11.3.2.    Revenue Based Modeling
    11.4.    Phase III - Primary Research
    11.5.    Research Limitations
        11.5.1.    Assumptions
No Methodology
No Available